Cellectar Biosciences, Inc. (CLRB)
1.78
-0.09
(-4.81%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
Cellectar Biosciences Market Cap : 14.69M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 14.69M |
| October 01, 2026 | 15.43M |
| September 30, 2026 | 15.18M |
| September 29, 2026 | 15.02M |
| September 28, 2026 | 15.10M |
| September 25, 2026 | 14.85M |
| September 24, 2026 | 17.12M |
| September 23, 2026 | 17.25M |
| September 22, 2026 | 18.40M |
| September 21, 2026 | 19.39M |
| September 18, 2026 | 19.64M |
| September 17, 2026 | 19.80M |
| September 16, 2026 | 19.39M |
| September 15, 2026 | 19.14M |
| September 14, 2026 | 19.06M |
| September 11, 2026 | 19.06M |
| September 10, 2026 | 19.56M |
| September 09, 2026 | 19.52M |
| September 08, 2026 | 19.89M |
| September 04, 2026 | 19.56M |
| September 03, 2026 | 19.39M |
| September 02, 2026 | 20.05M |
| September 01, 2026 | 20.30M |
| August 31, 2026 | 20.71M |
| August 28, 2026 | 20.88M |
| Date | Value |
|---|---|
| August 27, 2026 | 20.96M |
| August 26, 2026 | 20.96M |
| August 25, 2026 | 20.96M |
| August 24, 2026 | 20.80M |
| August 21, 2026 | 21.37M |
| August 20, 2026 | 21.37M |
| August 19, 2026 | 21.62M |
| August 18, 2026 | 21.37M |
| August 17, 2026 | 21.13M |
| August 14, 2026 | 21.46M |
| August 13, 2026 | 20.47M |
| August 12, 2026 | 21.46M |
| August 11, 2026 | 21.79M |
| August 10, 2026 | 21.46M |
| August 07, 2026 | 10.90M |
| August 06, 2026 | 10.69M |
| August 05, 2026 | 10.69M |
| August 04, 2026 | 10.85M |
| August 03, 2026 | 11.28M |
| July 31, 2026 | 10.90M |
| July 30, 2026 | 10.73M |
| July 29, 2026 | 10.52M |
| July 28, 2026 | 10.60M |
| July 27, 2026 | 10.26M |
| July 24, 2026 | 10.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| Price to Book Value | 0.4917 |
| Price | 1.78 |
| Earnings Yield | -255.9% |